Pfizer Inc. and its partner BioNTech said on Thursday the EU health regulator has recommended authorizing the use of their bivalent COVID-19 shot as a booster in children aged 5 through 11.
Tag Archive for: COVID booster
Britain’s health regulator on Wednesday approved a COVID-19 booster from Pfizer Inc and partner BioNTech SE targeting the Omicron BA.4 and BA.5 sub-variants and the original coronavirus strain.
U.S. drugmaker Pfizer Inc and its German partner BioNTech SE said on Friday their Omicron-tailored shot targeting the BA.4/5 subvariants produced a strong antibody response in humans than the original shot after one month.
Swiss drugs regulator Swissmedic said it had been informed by vaccination centers of the appearance of bubbles during the preparation of the updated vaccine from Pfizer and BioNTech targeting the original version of the coronavirus and the BA.1 Omicron variant that led to a record surge in cases last winter.
The authorization applies for people unable to get updated Omicron-tailored boosters, or those who would choose not to receive any other booster dose.
Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants, generated a strong immune response and was well tolerated in testing on humans.
The Moderna COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to six years of age. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent is authorized for administration at least two months following completion of primary or booster vaccination in children down to five years of age.
Pfizer Inc. and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration’s authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years.
Today, the agency amended the EUAs of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine to authorize bivalent formulations of the vaccines for use as a single booster dose at least two months following primary or booster vaccination.
Moderna Inc will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus to Canada, the company said on Monday.
